Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Peripheral Blood Stem Cells

Partially matched related donor peripheral blood progenitor cell transplantation in paediatric patients adding fludarabine and anti-lymphocyte gamma-globulin

Bone Marrow Transplantation volume 30, pages 359–366 (2002)Cite this article

Abstract

Twenty-one paediatric patients (11 males and 10 females) received a CD34-selected partially matched related donor transplant for malignant (16 cases) and non-malignant conditions (five cases). The average cell dose was 11.13 × 106/kg. Fifteen of 16 patients with malignant conditions and one with non-malignant disease received total body irradiation plus cyclophosphamide. Three of 5 patients with non-malignant conditions and one with leukaemia, received busulphan plus cyclophosphamide. One patient with Fanconi anaemia received 100 mg/kg of cyclophosphamide. Fludarabine (25 mg/m2/day for 5 days) was administered prior to all these regimens. Additionally, anti-lymphocyte gamma-globulin (12.5 mg/kg/day) was administered from day −2 to day +2. Three (15%) patients failed to achieve complete chimaerism (CC). These patients received a second cell infusion. Two of them achieved CC. In the third patient, the percentage of donor cells was increased. The likelihood for engraftment was not related to the cell dose received. Acute graft-versus-host disease (GVHD) occurred in nine patients but only one developed GVHD >grade II. Eight patients developed active viral infections, which resolved after treatment. Patients receiving cell doses higher than our average had a significantly faster CD3 and CD4 cell recovery and experienced a lower incidence of viral infections. After 480 ± 255 days of median follow-up, 16/21 patients are alive and well and have CC. Three patients died of leukaemic relapse and a fourth from progression of his disease (adreno-leuko-dystrophy). We conclude that partially matched related donors are a feasible source of haemopoietic progenitor cells for transplantation for patients without matched familial or unrelated donors.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Dini G, Cornish JM, Gadner H et al. Bone marrow transplant indications for childhood leukemias: achieving a consensus. The EBMT Pediatric Diseases Working Party Bone Marrow Transplant 1996 18 (Suppl. 2): S4 7

    Google Scholar 

  2. Speiser DE, Hermans J, van Biezen A et al. Haploidentical family member transplants for patients with chronic myeloid leukaemia: a report of the Chronic Leukaemia Working Party of European Group for Blood and Marrow Transplantation (EBMT) Bone Marrow Transplant 1997 19: 1197 1203

    Article  CAS  PubMed  Google Scholar 

  3. Nagler A, Brautbar C, Slavin S, Bishara A . Bone marrow transplantation using unrelated and family related donors: the impact of HLA-C disparity Bone Marrow Transplant 1996 18: 891 897

    CAS  PubMed  Google Scholar 

  4. Polchi P, Lucarelli G, Galimberti M et al. Haploidentical bone marrow transplantation from mother to child with advanced leukemia Bone Marrow Transplant 1995 16: 529 535

    CAS  PubMed  Google Scholar 

  5. Passweg JR, Kuhne T, Gregor M et al. Increased stem cell dose, as obtained using currently available technology, may not be sufficient for engraftment of haploidentical stem cell transplants Bone Marrow Transplant 2000 26: 1033 1036

    Article  CAS  PubMed  Google Scholar 

  6. Kawano Y, Takaue Y, Watanabe A et al. Partially mismatched pediatric transplants with allogeneic CD34(+) blood cells from a related donor Blood 1998 92: 3123 3130

    CAS  PubMed  Google Scholar 

  7. Henslee-Downey PJ, Abhyankar SH, Parrish RS et al. Use of partially mismatched related donors extends access to allogeneic marrow transplant Blood 1997 89: 3864 3872

    CAS  PubMed  Google Scholar 

  8. Henslee-Downey PJ . Mismatched bone marrow transplantation Curr Opin Oncol 1995 7: 115 121

    Article  CAS  PubMed  Google Scholar 

  9. Peters C, Matthes-Martin S, Fritsch G et al. Transplantation of highly purified peripheral blood CD34+ cells from HLA-mismatched parental donors in 14 children: evaluation of early monitoring of engraftment Leukemia 1999 13: 2070 2078

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Veys PA, Meral A, Hassan A et al. Haploidentical related transplants and unrelated donor transplants with T cell addback Bone Marrow Transplant 1998 21 (Suppl. 2): S42 44

    Google Scholar 

  11. Bunjes D, Duncker C, Wiesneth M et al. CD34+ selected cells in mismatched stem cell transplantation: a single centre experience of haploidentical peripheral blood stem cell transplantation Bone Marrow Transplant 2000 25 (Suppl. 2): S9 11

    Article  Google Scholar 

  12. Handgretinger R, Schumm M, Lang P et al. Transplantation of megadoses of purified haploidentical stem cells Ann NY Acad Sci 1999 872: 351 361

    Article  CAS  PubMed  Google Scholar 

  13. Ortin M, Passant M, Saul P, Darbyshire PJ . Fludarabine-based conditioning regimes for related haploidentical stem-cell transplantation Bone Marrow Transplant 2000 25 (Suppl. 1): S34

    Google Scholar 

  14. Kapelushnik J, Mandel H, Varadi G, Nagler A . Fludarabine-based protocol for haploidentical peripheral blood stem cell transplantation in Hurler syndrome J Pediatr Hematol Oncol 2000 22: 433 436

    Article  CAS  PubMed  Google Scholar 

  15. Klingebiel TE, Lang P, Schumm M et al. Current results in haploidentical stem cell transplantation in children Bone Marrow Transplant 2000 25 (Suppl. 1): S1

    Google Scholar 

  16. Huang P, Chubb S, Plunkett W . Termination of DNA synthesis by 9-β-D-arabinofuranosyl-2-fluoroadenine: a mechanism for cytotoxicity J Biol Chem 1990 265: 16617 16625

    CAS  PubMed  Google Scholar 

  17. Giralt S, Estey E, Albitar M et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy Blood 1997 89: 4531 4536

    CAS  PubMed  Google Scholar 

  18. Slavin S, Nagler A, Naparstek E et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases Blood 1998 91: 756 763

    CAS  PubMed  Google Scholar 

  19. Dokal IS, Roberts IA . Bone marrow transplantation for Fanconi's anaemia: conditioning with reduced doses of cyclophosphamide without radiation Br J Haematol 1996 94: 423

    CAS  PubMed  Google Scholar 

  20. Aversa F, Martelli MM, Reisner Y . Use of stem cells from mismatched related donors Curr Opin Hematol 1997 4: 419 422

    Article  CAS  PubMed  Google Scholar 

  21. Reisner Y, Martelli MF . Transplantation tolerance induced by ‘mega dose’ CD34+ cell transplants Exp Hematol 2000 28: 119 127

    Article  CAS  PubMed  Google Scholar 

  22. Gandy KL, Domen J, Aguila H, Weissman IL . CD8+TCR+ and CD8+TCR− cells in whole bone marrow facilitate the engraftment of hematopoietic stem cells across allogeneic barriers Immunity 1999 11: 579 590

    Article  CAS  PubMed  Google Scholar 

  23. Bader P, Beck J, Schlegel PG et al. Additional immunotherapy on the basis of increasing mixed hematopoietic chimerism after allogeneic BMT in children with acute leukemia: is there an option to prevent relapse? Bone Marrow Transplant 1997 20: 79 81

    Article  CAS  PubMed  Google Scholar 

  24. Nagler A, Ackerstein A, Or R et al. Adoptive immunotherapy with haploidentical allogeneic peripheral blood lymphocytes following autologous bone marrow transplantation Exp Hematol 2000 28: 1225 1231

    Article  CAS  PubMed  Google Scholar 

  25. Bowers E, Tamaki S, Coward A et al. Differing functional recovery of donor-derived immune cells after purified haploidentical and fully mismatched hematopoietic stem cell transplantation in mice Exp Hematol 2000 28: 1481 1489

    Article  CAS  PubMed  Google Scholar 

  26. Gross TG, Steinbuch M, DeFor T et al. B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome Bone Marrow Transplant 1999 23: 251 258

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Ruggeri L, Capanni M, Casucci M et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation Blood 1999 94: 333 339

    CAS  PubMed  Google Scholar 

  28. Henslee-Downey PJ . Haploidentical transplantation Cancer Treat Res 1999 101: 53 77

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to acknowledge Dr S Meller and Prof CR Pinkerton for their critical review of this article.

Author information

Authors and Affiliations

  1. Department of Haematology and Oncology, The Bone Marrow Transplant Unit, The Birmingham Children's Hospital, Birmingham, UK

    M Ortín, R Raj, E Kinning, M Williams & PJ Darbyshire

Authors
  1. M Ortín
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R Raj
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E Kinning
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M Williams
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. PJ Darbyshire
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ortín, M., Raj, R., Kinning, E. et al. Partially matched related donor peripheral blood progenitor cell transplantation in paediatric patients adding fludarabine and anti-lymphocyte gamma-globulin. Bone Marrow Transplant 30, 359–366 (2002). https://doi.org/10.1038/sj.bmt.1703667

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703667

Keywords

This article is cited by

Search

Advanced search

Quick links